MedPath

Neuromuscular Electrical Stimulation in Patients With Interstitial Lung Disease

Not Applicable
Completed
Conditions
Interstitial Lung Disease
Registration Number
NCT02497144
Lead Sponsor
Gazi University
Brief Summary

Decreased exercise capacity and quality of life, increased dyspnea and fatigue perception and hypoxemia during exercise is seen in patients with interstitial lung disease. Impaired ventilatory response, increased lung compliance, ventilation-perfusion mismatching and inadequate peripheral circulation causes decreased exercise capacity. Another important factor that induce decreased exercise capacity is peripheral muscle weakness. In literature, there is no study investigated effects of neuromuscular electrical stimulation on functional exercise capacity, respiratory and peripheral muscle strength, pulmonary functions, physical activity level, dyspnea and fatigue perception in patients with interstitial lung disease.

Detailed Description

In literature, there was increased quantity of study investigated effects of neuromuscular electrical stimulation in chronic lung disease patients. It was used as a pulmonary rehabilitation component especially in patients with decreased exercise capacity and peripheral muscle strength, intensely increased dyspnea inhibits exercise. It was demonstrated that neuromuscular electrical stimulation improved functional exercise capacity, peripheral muscle strength and quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosed with interstitial lung disease
  • Clinically stable
  • Under standard medication
  • Having no exacerbation or infection
Exclusion Criteria
  • Cognitive disorders
  • Orthopedic and neurological problems
  • Contraindications to apply the neuromuscular electrical stimulation (pace maker, sensory defects, etc...)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Functional exercise capacity6 weeks

Six minute walk test

Secondary Outcome Measures
NameTimeMethod
Depression6 weeks

Montgomery Asberg Depression Rating Scale (MADRS) (Turkish versions of all scales)

Generic quality of life6 weeks

Short Form (SF-36) Health Survey

Disease specific quality of life6 weeks

Saint George Quality of Life Questionnaire

Inspiratory and expiratory muscle strength (MIP,MEP)6 weeks

Mouth pressure device

Dyspnea6 weeks

Modified Borg and Modified Medical Research Council (MMRC) Dyspnea scales

Peripheral muscle strength6 weeks

Hand held dynamometer

Fatigue6 weeks

Fatigue Severity Scale

Physical activity6 weeks

Metabolic holter

Cough related quality of life6 weeks

Leicester Cough Questionnaire

Maximal exercise capacity6 weeks

Incremental shuttle walk test

Pulmonary functions6 weeks

Spirometry

Trial Locations

Locations (1)

Gazi University

🇹🇷

Ankara, Turkey

Gazi University
🇹🇷Ankara, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.